 |
Justin Petrone is the editor of GenomeWeb's BioArray News and covers the microarray and biochip sector of the genomics market. E-mail Justin Petrone or follow his GenomeWeb Twitter account at @BioArrayNews. |
In Sluggish World Economy, Array Companies Encouraged by China's Fast Growing Clinical Market
November 27, 2012
In Sluggish World Economy, Array Companies Encouraged by China's Fast Growing Clinical Market
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- At JP Morgan, Affy Provides Update on Cyto FDA Submission, New Genotyping Products, Restructuring
January 15, 2013 / BioArray News - Affymetrix to Start Clinical Trials for CytoScan HD in March, Plans FDA Submission by Midyear
January 17, 2012 / BioArray News - Affymetrix to Launch Next-Gen Cytogenetics Array in Q3, Plans FDA Submission
May 10, 2011 / BioArray News - Despite Continued Genotyping Growth, Weak Expression Sales Force Affymetrix to Suspend Guidance
May 7, 2013 / BioArray News - Consumer Genetics Sales, GWAS, BlueGnome Drive Illumina Q1 Microarray Revenue Growth
April 23, 2013 / BioArray News